APO Research
Talk to an analyst

APO RESEARCH · REPORT

Cyclizine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Cyclizine Industry Growth and Trends Forecast to 2032

19 December 2025102 pages

Choose your research edition.

Industry ResearchCyclizine Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Cyclizine Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Cyclizine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Cyclizine Market Outlook and Growth Opportunities 2026190 pages · $4,250 USDMarket Analysis & ForecastGlobal Cyclizine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Cyclizine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Cyclizine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Cyclizine include Teva, Glaxosmithkline, Wockhardt UK, Wabosan Arzneimittel, Pharmascript Limited, P and D Pharmaceuticals, Be-Tabs Pharmaceuticals, Aspen Pharmacare and Amoun Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Cyclizine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Cyclizine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Cyclizine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Cyclizine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Cyclizine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Cyclizine Market by Company

Teva

Glaxosmithkline

Wockhardt UK

Wabosan Arzneimittel

Pharmascript Limited

P and D Pharmaceuticals

Be-Tabs Pharmaceuticals

Aspen Pharmacare

Amoun Pharmaceutical

Amco

Aft Pharmaceuticals

Advanz Pharma

Cyclizine Segment by Type

Oral

Injection

Cyclizine Segment by Application

Migraine

Motion Sickness

Cyclizine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cyclizine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Cyclizine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cyclizine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Cyclizine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Cyclizine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Oral Table 2. Major Company of Injection Table 3. Global Cyclizine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Cyclizine Sales by Type (2021-2026) & (K Units) Table 5. Global Cyclizine Sales Market Share in Volume by Type (2021-2026) Table 6. Global Cyclizine Sales by Type (2021-2026) & (US$ Million) Table 7. Global Cyclizine Sales Market Share in Value by Type (2021-2026) Table 8. Global Cyclizine Price by Type (2021-2026) & (US$/Unit) Table 9. Global Cyclizine Sales by Type (2027-2032) & (K Units) Table 10. Global Cyclizine Sales Market Share in Volume by Type (2027-2032) Table 11. Global Cyclizine Sales by Type (2027-2032) & (US$ Million) Table 12. Global Cyclizine Sales Market Share in Value by Type (2027-2032) Table 13. Global Cyclizine Price by Type (2027-2032) & (US$/Unit) Table 14. North America Cyclizine Sales by Type (2021-2026) & (K Units) Table 15. North America Cyclizine Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Cyclizine Sales by Type (2021-2026) & (K Units) Table 17. Europe Cyclizine Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Cyclizine Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Cyclizine Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Cyclizine Sales by Type (2021-2026) & (K Units) Table 21. Latin America Cyclizine Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Cyclizine Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Cyclizine Sales by Type (2021-2026) & (US$ Million) Table 24. Cyclizine Industry Trends Table 25. Cyclizine Industry Drivers Table 26. Cyclizine Industry Opportunities and Challenges Table 27. Cyclizine Industry Restraints Table 28. Global Cyclizine Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Cyclizine Revenue Market Share by Company (2021-2026) Table 30. Global Cyclizine Sales by Company (2021-2026) & (K Units) Table 31. Global Cyclizine Sales Share by Company (2021-2026) Table 32. Global Cyclizine Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Cyclizine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Cyclizine Major Company Production Sites and Headquarters Table 35. Global Cyclizine Company, Product Type & Application Table 36. Global Cyclizine Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Cyclizine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Cyclizine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Cyclizine Sales by Region (2021-2026) & (K Units) Table 41. Global Cyclizine Sales Market Share in Volume by Region (2021-2026) Table 42. Global Cyclizine Sales by Region (2021-2026) & (US$ Million) Table 43. Global Cyclizine Sales Market Share in Value by Region (2021-2026) Table 44. Global Cyclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Cyclizine Sales by Region (2027-2032) & (K Units) Table 46. Global Cyclizine Sales Market Share in Volume by Region (2027-2032) Table 47. Global Cyclizine Sales by Region (2027-2032) & (US$ Million) Table 48. Global Cyclizine Sales Market Share in Value by Region (2027-2032) Table 49. Global Cyclizine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Cyclizine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Cyclizine Sales by Application (2021-2026) & (K Units) Table 52. Global Cyclizine Sales Market Share in Volume by Application (2021-2026) Table 53. Global Cyclizine Sales by Application (2021-2026) & (US$ Million) Table 54. Global Cyclizine Sales Market Share in Value by Application (2021-2026) Table 55. Global Cyclizine Price by Application (2021-2026) & (US$/Unit) Table 56. Global Cyclizine Sales by Application (2027-2032) & (K Units) Table 57. Global Cyclizine Sales Market Share in Volume by Application (2027-2032) Table 58. Global Cyclizine Sales by Application (2027-2032) & (US$ Million) Table 59. Global Cyclizine Sales Market Share in Value by Application (2027-2032) Table 60. Global Cyclizine Price by Application (2027-2032) & (US$/Unit) Table 61. North America Cyclizine Sales by Application (2021-2026) & (K Units) Table 62. North America Cyclizine Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Cyclizine Sales by Application (2021-2026) & (K Units) Table 64. Europe Cyclizine Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Cyclizine Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Cyclizine Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Cyclizine Sales by Application (2021-2026) & (K Units) Table 68. Latin America Cyclizine Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Cyclizine Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Cyclizine Sales by Application (2021-2026) & (US$ Million) Table 71. Teva Company Information Table 72. Teva Business Overview Table 73. Teva Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Teva Cyclizine Product Portfolio Table 75. Teva Recent Development Table 76. Glaxosmithkline Company Information Table 77. Glaxosmithkline Business Overview Table 78. Glaxosmithkline Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Glaxosmithkline Cyclizine Product Portfolio Table 80. Glaxosmithkline Recent Development Table 81. Wockhardt UK Company Information Table 82. Wockhardt UK Business Overview Table 83. Wockhardt UK Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Wockhardt UK Cyclizine Product Portfolio Table 85. Wockhardt UK Recent Development Table 86. Wabosan Arzneimittel Company Information Table 87. Wabosan Arzneimittel Business Overview Table 88. Wabosan Arzneimittel Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Wabosan Arzneimittel Cyclizine Product Portfolio Table 90. Wabosan Arzneimittel Recent Development Table 91. Pharmascript Limited Company Information Table 92. Pharmascript Limited Business Overview Table 93. Pharmascript Limited Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Pharmascript Limited Cyclizine Product Portfolio Table 95. Pharmascript Limited Recent Development Table 96. P and D Pharmaceuticals Company Information Table 97. P and D Pharmaceuticals Business Overview Table 98. P and D Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. P and D Pharmaceuticals Cyclizine Product Portfolio Table 100. P and D Pharmaceuticals Recent Development Table 101. Be-Tabs Pharmaceuticals Company Information Table 102. Be-Tabs Pharmaceuticals Business Overview Table 103. Be-Tabs Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Be-Tabs Pharmaceuticals Cyclizine Product Portfolio Table 105. Be-Tabs Pharmaceuticals Recent Development Table 106. Aspen Pharmacare Company Information Table 107. Aspen Pharmacare Business Overview Table 108. Aspen Pharmacare Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Aspen Pharmacare Cyclizine Product Portfolio Table 110. Aspen Pharmacare Recent Development Table 111. Amoun Pharmaceutical Company Information Table 112. Amoun Pharmaceutical Business Overview Table 113. Amoun Pharmaceutical Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Amoun Pharmaceutical Cyclizine Product Portfolio Table 115. Amoun Pharmaceutical Recent Development Table 116. Amco Company Information Table 117. Amco Business Overview Table 118. Amco Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Amco Cyclizine Product Portfolio Table 120. Amco Recent Development Table 121. Aft Pharmaceuticals Company Information Table 122. Aft Pharmaceuticals Business Overview Table 123. Aft Pharmaceuticals Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 124. Aft Pharmaceuticals Cyclizine Product Portfolio Table 125. Aft Pharmaceuticals Recent Development Table 126. Advanz Pharma Company Information Table 127. Advanz Pharma Business Overview Table 128. Advanz Pharma Cyclizine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 129. Advanz Pharma Cyclizine Product Portfolio Table 130. Advanz Pharma Recent Development Table 131. North America Cyclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. North America Cyclizine Sales by Country (2021-2026) & (K Units) Table 133. North America Cyclizine Sales Market Share by Country (2021-2026) Table 134. North America Cyclizine Sales Forecast by Country (2027-2032) & (K Units) Table 135. North America Cyclizine Sales Market Share Forecast by Country (2027-2032) Table 136. North America Cyclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. North America Cyclizine Market Size by Country (2021-2026) & (US$ Million) Table 138. North America Cyclizine Market Share by Country (2021-2026) Table 139. North America Cyclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. North America Cyclizine Market Share Forecast by Country (2027-2032) Table 141. Europe Cyclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Europe Cyclizine Sales by Country (2021-2026) & (K Units) Table 143. Europe Cyclizine Sales Market Share by Country (2021-2026) Table 144. Europe Cyclizine Sales Forecast by Country (2027-2032) & (K Units) Table 145. Europe Cyclizine Sales Market Share Forecast by Country (2027-2032) Table 146. Europe Cyclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Europe Cyclizine Market Size by Country (2021-2026) & (US$ Million) Table 148. Europe Cyclizine Market Share by Country (2021-2026) Table 149. Europe Cyclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Europe Cyclizine Market Share Forecast by Country (2027-2032) Table 151. Asia-Pacific Cyclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Asia-Pacific Cyclizine Sales by Country (2021-2026) & (K Units) Table 153. Asia-Pacific Cyclizine Sales Market Share by Country (2021-2026) Table 154. Asia-Pacific Cyclizine Sales Forecast by Country (2027-2032) & (K Units) Table 155. Asia-Pacific Cyclizine Sales Market Share Forecast by Country (2027-2032) Table 156. Asia-Pacific Cyclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Asia-Pacific Cyclizine Market Size by Country (2021-2026) & (US$ Million) Table 158. Asia-Pacific Cyclizine Market Share by Country (2021-2026) Table 159. Asia-Pacific Cyclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Asia-Pacific Cyclizine Market Share Forecast by Country (2027-2032) Table 161. Latin America Cyclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 162. Latin America Cyclizine Sales by Country (2021-2026) & (K Units) Table 163. Latin America Cyclizine Sales Market Share by Country (2021-2026) Table 164. Latin America Cyclizine Sales Forecast by Country (2027-2032) & (K Units) Table 165. Latin America Cyclizine Sales Market Share Forecast by Country (2027-2032) Table 166. Latin America Cyclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Latin America Cyclizine Market Size by Country (2021-2026) & (US$ Million) Table 168. Latin America Cyclizine Market Share by Country (2021-2026) Table 169. Latin America Cyclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Latin America Cyclizine Market Share Forecast by Country (2027-2032) Table 171. Middle East and Africa Cyclizine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 172. Middle East and Africa Cyclizine Sales by Country (2021-2026) & (K Units) Table 173. Middle East and Africa Cyclizine Sales Market Share by Country (2021-2026) Table 174. Middle East and Africa Cyclizine Sales Forecast by Country (2027-2032) & (K Units) Table 175. Middle East and Africa Cyclizine Sales Market Share Forecast by Country (2027-2032) Table 176. Middle East and Africa Cyclizine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Middle East and Africa Cyclizine Market Size by Country (2021-2026) & (US$ Million) Table 178. Middle East and Africa Cyclizine Market Share by Country (2021-2026) Table 179. Middle East and Africa Cyclizine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Middle East and Africa Cyclizine Market Share Forecast by Country (2027-2032) Table 181. Key Raw Materials Table 182. Raw Materials Key Suppliers Table 183. Cyclizine Distributors List Table 184. Cyclizine Customers List Table 185. Research Programs/Design for This Report Table 186. Authors List of This Report Table 187. Secondary Sources Table 188. Primary Sources List of Figures Figure 1. Cyclizine Image Figure 2. Global Cyclizine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Cyclizine Market Size (2021-2032) & (US$ Million) Figure 4. Global Cyclizine Sales (2021-2032) & (K Units) Figure 5. Oral Image Figure 6. Global Oral Sales YoY Growth (2021-2032) & (K Units) Figure 7. Injection Image Figure 8. Global Injection Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Cyclizine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Cyclizine Market Share by Type 2025 VS 2032 Figure 11. North America Cyclizine Sales Market Share in Volume by Type in 2025 Figure 12. North America Cyclizine Sales Market Share in Value by Type in 2025 Figure 13. Europe Cyclizine Sales Market Share in Volume by Type in 2025 Figure 14. Europe Cyclizine Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Cyclizine Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Cyclizine Sales Market Share in Value by Type in 2025 Figure 17. Latin America Cyclizine Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Cyclizine Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Cyclizine Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Cyclizine Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Cyclizine Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Migraine Image Figure 24. Global Migraine Sales YoY Growth (2021-2032) & (K Units) Figure 25. Motion Sickness Image Figure 26. Global Motion Sickness Sales YoY Growth (2021-2032) & (K Units) Figure 27. Global Cyclizine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Cyclizine Market Share by Application 2025 VS 2032 Figure 29. North America Cyclizine Sales Market Share in Volume by Application in 2025 Figure 30. North America Cyclizine Sales Market Share in Value by Application in 2025 Figure 31. Europe Cyclizine Sales Market Share in Volume by Application in 2025 Figure 32. Europe Cyclizine Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Cyclizine Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Cyclizine Sales Market Share in Value by Application in 2025 Figure 35. Latin America Cyclizine Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Cyclizine Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Cyclizine Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Cyclizine Sales Market Share in Value by Application in 2025 Figure 39. North America Cyclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 40. North America Cyclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Cyclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Cyclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Cyclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. Europe Cyclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Cyclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Cyclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Cyclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Asia-Pacific Cyclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Cyclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Cyclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Cyclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Latin America Cyclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Cyclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Cyclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Cyclizine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Middle East and Africa Cyclizine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Cyclizine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Cyclizine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Cyclizine Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Cyclizine Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Oral
  • Injection
Applications
  • Migraine
  • Motion Sickness
Companies covered
  • Teva
  • Glaxosmithkline
  • Wockhardt UK
  • Wabosan Arzneimittel
  • Pharmascript Limited
  • P and D Pharmaceuticals
  • Be-Tabs Pharmaceuticals
  • Aspen Pharmacare
  • Amoun Pharmaceutical
  • Amco
  • Aft Pharmaceuticals
  • Advanz Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Cyclizine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Cyclizine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Cyclizine Market by Type
  6. 1.3.1 Oral
  7. 1.3.2 Injection
  8. 1.4 Global Cyclizine Market Size by Type
  9. 1.4.1 Global Cyclizine Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Cyclizine Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Cyclizine Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Cyclizine Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Cyclizine Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Cyclizine Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Cyclizine Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Cyclizine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Cyclizine Industry Trends
  2. 2.2 Cyclizine Industry Drivers
  3. 2.3 Cyclizine Industry Opportunities and Challenges
  4. 2.4 Cyclizine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Cyclizine Revenue (2021-2026)
  2. 3.2 Global Top Players by Cyclizine Sales (2021-2026)
  3. 3.3 Global Top Players by Cyclizine Price (2021-2026)
  4. 3.4 Global Cyclizine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Cyclizine Major Company Production Sites & Headquarters
  6. 3.6 Global Cyclizine Company, Product Type & Application
  7. 3.7 Global Cyclizine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Cyclizine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Cyclizine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Cyclizine Tier 1, Tier 2, and Tier 3
4 Cyclizine Regional Status and Outlook
  1. 4.1 Global Cyclizine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Cyclizine Historic Market Size by Region
  3. 4.2.1 Global Cyclizine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Cyclizine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Cyclizine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Cyclizine Forecasted Market Size by Region
  7. 4.3.1 Global Cyclizine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Cyclizine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Cyclizine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Cyclizine by Application
  1. 5.1 Cyclizine Market by Application
  2. 5.1.1 Migraine
  3. 5.1.2 Motion Sickness
  4. 5.2 Global Cyclizine Market Size by Application
  5. 5.2.1 Global Cyclizine Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Cyclizine Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Cyclizine Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Cyclizine Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Cyclizine Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Cyclizine Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Cyclizine Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Cyclizine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Teva
  2. 6.1.1 Teva Company Information
  3. 6.1.2 Teva Business Overview
  4. 6.1.3 Teva Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Teva Cyclizine Product Portfolio
  6. 6.1.5 Teva Recent Developments
  7. 6.2 Glaxosmithkline
  8. 6.2.1 Glaxosmithkline Company Information
  9. 6.2.2 Glaxosmithkline Business Overview
  10. 6.2.3 Glaxosmithkline Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Glaxosmithkline Cyclizine Product Portfolio
  12. 6.2.5 Glaxosmithkline Recent Developments
  13. 6.3 Wockhardt UK
  14. 6.3.1 Wockhardt UK Company Information
  15. 6.3.2 Wockhardt UK Business Overview
  16. 6.3.3 Wockhardt UK Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Wockhardt UK Cyclizine Product Portfolio
  18. 6.3.5 Wockhardt UK Recent Developments
  19. 6.4 Wabosan Arzneimittel
  20. 6.4.1 Wabosan Arzneimittel Company Information
  21. 6.4.2 Wabosan Arzneimittel Business Overview
  22. 6.4.3 Wabosan Arzneimittel Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Wabosan Arzneimittel Cyclizine Product Portfolio
  24. 6.4.5 Wabosan Arzneimittel Recent Developments
  25. 6.5 Pharmascript Limited
  26. 6.5.1 Pharmascript Limited Company Information
  27. 6.5.2 Pharmascript Limited Business Overview
  28. 6.5.3 Pharmascript Limited Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Pharmascript Limited Cyclizine Product Portfolio
  30. 6.5.5 Pharmascript Limited Recent Developments
  31. 6.6 P and D Pharmaceuticals
  32. 6.6.1 P and D Pharmaceuticals Company Information
  33. 6.6.2 P and D Pharmaceuticals Business Overview
  34. 6.6.3 P and D Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 P and D Pharmaceuticals Cyclizine Product Portfolio
  36. 6.6.5 P and D Pharmaceuticals Recent Developments
  37. 6.7 Be-Tabs Pharmaceuticals
  38. 6.7.1 Be-Tabs Pharmaceuticals Company Information
  39. 6.7.2 Be-Tabs Pharmaceuticals Business Overview
  40. 6.7.3 Be-Tabs Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Be-Tabs Pharmaceuticals Cyclizine Product Portfolio
  42. 6.7.5 Be-Tabs Pharmaceuticals Recent Developments
  43. 6.8 Aspen Pharmacare
  44. 6.8.1 Aspen Pharmacare Company Information
  45. 6.8.2 Aspen Pharmacare Business Overview
  46. 6.8.3 Aspen Pharmacare Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Aspen Pharmacare Cyclizine Product Portfolio
  48. 6.8.5 Aspen Pharmacare Recent Developments
  49. 6.9 Amoun Pharmaceutical
  50. 6.9.1 Amoun Pharmaceutical Company Information
  51. 6.9.2 Amoun Pharmaceutical Business Overview
  52. 6.9.3 Amoun Pharmaceutical Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Amoun Pharmaceutical Cyclizine Product Portfolio
  54. 6.9.5 Amoun Pharmaceutical Recent Developments
  55. 6.10 Amco
  56. 6.10.1 Amco Company Information
  57. 6.10.2 Amco Business Overview
  58. 6.10.3 Amco Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Amco Cyclizine Product Portfolio
  60. 6.10.5 Amco Recent Developments
  61. 6.11 Aft Pharmaceuticals
  62. 6.11.1 Aft Pharmaceuticals Company Information
  63. 6.11.2 Aft Pharmaceuticals Business Overview
  64. 6.11.3 Aft Pharmaceuticals Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Aft Pharmaceuticals Cyclizine Product Portfolio
  66. 6.11.5 Aft Pharmaceuticals Recent Developments
  67. 6.12 Advanz Pharma
  68. 6.12.1 Advanz Pharma Company Information
  69. 6.12.2 Advanz Pharma Business Overview
  70. 6.12.3 Advanz Pharma Cyclizine Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Advanz Pharma Cyclizine Product Portfolio
  72. 6.12.5 Advanz Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Cyclizine Sales by Country
  2. 7.1.1 North America Cyclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Cyclizine Sales by Country (2021-2026)
  4. 7.1.3 North America Cyclizine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Cyclizine Market Size by Country
  6. 7.2.1 North America Cyclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Cyclizine Market Size by Country (2021-2026)
  8. 7.2.3 North America Cyclizine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Cyclizine Sales by Country
  2. 8.1.1 Europe Cyclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Cyclizine Sales by Country (2021-2026)
  4. 8.1.3 Europe Cyclizine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Cyclizine Market Size by Country
  6. 8.2.1 Europe Cyclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Cyclizine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Cyclizine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Cyclizine Sales by Country
  2. 9.1.1 Asia-Pacific Cyclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Cyclizine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Cyclizine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Cyclizine Market Size by Country
  6. 9.2.1 Asia-Pacific Cyclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Cyclizine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Cyclizine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Cyclizine Sales by Country
  2. 10.1.1 South America Cyclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Cyclizine Sales by Country (2021-2026)
  4. 10.1.3 South America Cyclizine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Cyclizine Market Size by Country
  6. 10.2.1 South America Cyclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Cyclizine Market Size by Country (2021-2026)
  8. 10.2.3 South America Cyclizine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Cyclizine Sales by Country
  2. 11.1.1 Middle East and Africa Cyclizine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Cyclizine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Cyclizine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Cyclizine Market Size by Country
  6. 11.2.1 Middle East and Africa Cyclizine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Cyclizine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Cyclizine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Cyclizine Value Chain Analysis
  2. 12.1.1 Cyclizine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Cyclizine Production Mode & Process
  7. 12.2 Cyclizine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Cyclizine Distributors
  10. 12.2.3 Cyclizine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst